4th Quarter - Report

THE CONAFAY GROUP, LLC for CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation related to DISARM and R&D tax credit and biologics.

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
WILLIAM A. FRANCO —
EMILY WHEELER New Intern, Rep. DeFazio

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.